Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04907968
Title Study of Upifitamab Rilsodotin in Combination With Other Agent(s) in Participants With High-grade Serous Ovarian Cancer (UPGRADE)
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Mersana Therapeutics

fallopian tube cancer

ovarian cancer

peritoneum cancer


Carboplatin + XMT-1536

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.